INTRODUCTION
Attempts to determine the three-dimensional structure of the hematopoietic growth factor erythropoietin (Epo) have met with little success to date. The length of the polypeptide chain (165 aa.) precludes analysis by currently available NMR techniques. Furthermore, the high carbohydrate content of the glycoprotein (approx. 40% by weight) has interfered with attempts at crystallization.
Although the deglycosylated hormone remains biologically active, it forms complex aggregates, thereby closing this avenue for obtaining meaningful x-ray detraction patterns.
Several alternative approaches have been employed to elucidate Epo's structural and functional properties. Specifically, the methods used to identify those amino acid residues essential for the Epo/receptor interaction include: 1) the analysis of conserved sequences among mammalian Epos (1, 2); 2) immunochemical studies with site-specific antipeptide and/or monoclonal antibodies (3) (4) (5) (6) (7) (8) (9) (10) 3) mutant studies by means of deletion, linker-scanning, substitution and alanine scanning mutagenesis (11) (12) (13) (14) (15) ; 4) computer modeling (11, 14, 16, 17) . While each approach has provided useful information, a model structure that can reconcile all of the experimental data has not yet emerged.
In a previous series of immunochemical and mutagenesis-based studies, we identified amino acids 99-110 of the mature human Epo protein as forming part of a region of the molecule critical for both structure and function (5, 12) . Recently, we performed alanine-scanning mutagenesis and determined that the activities of mutants Serl04Ala, Leul05Ala and Leul08Ala were reduced to 16, 44 and 37% of wild-type Epo, respectively, while GlylOlAla was increased to 130% (13) . Most importantly Argl03Ala was completely inactive, even though immunochemical and thermal denaturation studies showed no significant overall structural alteration or destabilization. Another substitution, Arg 103 Asp, was also inactive, but was markedly more stable than wild-type. These results suggested a critical role for Arg 103 in receptor recognition.
We have now substituted Arg 103 with a series of charged and/or polar residues in order to determine the structural features of amino acid 103 required for biological activity. The results demonstrate that full biological activity is observed only with Arg at position 103. Moreover, the data strongly suggest that another positively charged residue lies in close proximity to Arg 103 in three-dimensional space and that interaction (or lack of interaction) between amino acid 103 and the other positively charged residue may have a major influence on the protein's structural stability.
MATERIALS AND METHODS

Construction of Epo variants
pSelect-Epo served as the starting material for all mutagenesis reactions (12, 15) .
Single-stranded DNA isolation and all subsequent mutagenesis steps were performed as described in the Altered Sites Mutagenesis Kit manual (Promega Corporation). Oligonucleotides were purchased from Genosys Biotechnologies, Inc. Each oligonucleotide cointroduced a specific codon change and a restriction endonuclease site (Hinfi) to facilitate screening for the desired mutant.
Individual colonies arising from the mutagenesis reaction were purified, and their plasmids were isolated by the alkaline-lysis procedure (18) . Plasmids were restricted with the appropriate enzyme (New England Biolabs) and the digests were fractionated on 1.7% agarose gels. The DNA was transferred to GeneScreen Plus (DuPont) and hybridized with a 32 P-labeled EcoBl fragment encoding Epo (12) . Clones containing the new restriction sites were sequenced by the dideoxynucleotide method (19) to verify the presence of the desired mutation and to confirm the sequence fidelity of the entire construct. The Kpnl-BglU. subfragment of each mutant was moved into pSV2-Epo (12) from which the corresponding wild-type sequences had been removed by restriction digestion. These constructs were used in all subsequent experiments.
Cell culture and transfections
COS 1 cells (ATCC) were maintained in Dulbecco's modified Eagles' medium containing 10%
fetal bovine serum (Gibco-BRL Life Technologies). Cells grown to 40-60% confluence were transfected with 5 ug DNA, using DEAE-dextran and 0.1 mM chloroquine (20) . Medium was collected 3 days post-transfection and centrifuged at 13,776 xg for 10 min to remove cell debris.
The biological activity of each sample was determined by the Krystal in vitro bioassay (21). Epo protein concentration was measured by competitive radioimmunoassay (RIA), calibrated against pure, recombinant human erythropoietin (INC Star).
Heat-stability assay
The heat stability of each mutant Epo molecule was evaluated as described previously (13).
Briefly, aliquots of conditioned medium from transfected COS cells were incubated at 56°C for specified time intervals. Samples were cooled on ice, then evaluated for structural integrity/denaturation by a conformational sensitive radioimmunoassay. Results are given in terms of the percentage of protein immunoprecipitated after heat treatment compared to untreated samples.
RESULTS
Construction and biological activity of erythropoietin mutants
Our previous experiments indicated that substitution of Arg 103 of wild-type recombinant human Epo with Ala abolished biological activity, whereas substitution of Arg 103 with the negatively charged Asp abolished biological activity and enhanced structural stability markedly (13) . Therefore, several amino acid substitutions were made at the position 103 of erythropoietin by site-directed mutagenesis in order to elucidate further the role of this Arg residue in the hormone's biological activity and structural stability. Besides the Arg 103 Ala and Arg 103 Asp mutants described previously, the following mutants were prepared: Argl03Asn, Argl03Gln, Argl03Glu, Argl03His
and Argl03Lys. The oligonucleotides used for the mutagenesis reactions are shown in Figure 1 .
Each oligonucleotide was designed to replace Arg 103 with an alternative residue and simultaneously to introduce a restriction endonuclease site (Hinfl) to facilitate screening. Clones identified by restriction analysis were sequenced to confirm sequence integrity and were transferred to the eukaryotic expression vector pSV2 (12) . These constructs were introduced subsequently into COS cells. After 72 hours, the transfected culture supernatants were harvested and tested for biological activity by in vitro bioassay. Epo protein concentrations were determined by radioimmunoassay.
All Epo mutants were synthesized and secreted efficiently by transfected cells (Table 1) .
Expression levels comparable to that seen for wild-type Epo were observed, indicating that none of the amino acid substitutions altered protein conformation drastically or affected transport. This finding agrees with our previous results for Argl03 substitution mutants (13) The specific activities of the mutant Epo molecules relative to wild-type Epo are shown in Figure 2 . Interestingly, two substitutions, Argl03His and Argl03Lys, resulted in recombinant proteins with specific activities equal to 2% and 25% that of wild-type protein, respectively. None of the other amino acid replacements generated proteins with detectable biological activity.
Heat stability of wild-type versus mutant erythropoietins
Wild-type Epo exhibits a time-dependent decrease in biological activity when incubated at 56°C or above (22) . We demonstrated previously (13) that a concomitant change in protein conformation of both biologically active (wild-type) and inactive Epo (Argl03Ala, Argl03Asp) could be monitored by radioimmunoassay which recognizes one or more heat-sensitive epitopes. These previous experiments showed that the stability of Argl03Ala was virtually identical to that of wildtype Epo, whereas the stability of Argl03Asp was much greater (13) . Therefore, we carried out heat stability assays on the new mutants to evaluate the effect of the Arg 103 substitutions on protein stability ( Figure 3 ).
As seen with Arg 103 Asp (13), introduction of a negatively charged Glu residue at position 11 103 (Argl03Glu) also resulted in a protein that was significantly more resistant than wild-type Epo to heat denaturation (Fig.3B) . Interestingly, the Asn substitution (Argl03Asn) also increased protein stability (Fig. 3A) . The stability of Argl03His was similar to wild-type (Fig. 3D) , whereas that of Argl03Gln (Fig. 3C ) was reduced slightly and that of Argl03Lys (Fig. 3E) was reduced substantially.
The stabilities of the positively charged mutants did not appear to follow a simple charge-based rule. The studies presented here emphasize the importance of Arg 103 for the biological activity of
Epo. Further characterization of this amino acid position by the methods noted above will greatly enhance our knowledge of Epo's structural and functional requirements for a productive Epo-Epo receptor interaction. Table 1 Erythropoietin protein concentrations in transfected COS1 cell medium. 
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